DE379436C - Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur - Google Patents

Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur

Info

Publication number
DE379436C
DE379436C DEK80769D DEK0080769D DE379436C DE 379436 C DE379436 C DE 379436C DE K80769 D DEK80769 D DE K80769D DE K0080769 D DEK0080769 D DE K0080769D DE 379436 C DE379436 C DE 379436C
Authority
DE
Germany
Prior art keywords
sulphurous acid
production
split
colloidal sulfur
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEK80769D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KABAN CHEM FABRIK GmbH
Original Assignee
KABAN CHEM FABRIK GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KABAN CHEM FABRIK GmbH filed Critical KABAN CHEM FABRIK GmbH
Priority to DEK80769D priority Critical patent/DE379436C/en
Application granted granted Critical
Publication of DE379436C publication Critical patent/DE379436C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung von Arzneimitteln, die schweflige Säure und kolloidalen Schwefel abspalten. Zur Behandlung von Sommerräude, Hufkrebs, Schafrotz und anderen Krankheiten dienen Arzneimittel, welche schweflige Säure und kolloidalen Schwefel abspalten (Berliner Tierärztliche Wochenschrift 1921, Nr. 49, Abhandlungen von Dr. med. vet. Blum, Berlin, und Dr. med. vet. Klein, Berlin). Diese Arzneimittel enthalten vornehmlich N atriumthiosulfat zusammen mit saueren Salzen behufs dessen Zersetzung. Trotz der Zugabe von Einhüllungsmitteln, wie Bolus, erleiden diese Salzgemische allmählich eine Zersetzung. Man kann nicht ohne weiteres erkennen, wie weit die Zersetzung fortgeschritten ist und ob das Gemisch bereits unwirksam geworden ist.Process for the manufacture of medicines containing sulphurous acid and split off colloidal sulfur. For the treatment of summer mange, hoof cancer, sheep stubborn and other diseases serve medicines, which sulphurous acid and colloidal Splitting off sulfur (Berliner Tierärztliche Wochenschrift 1921, No. 49, Abhandlungen by Dr. med. vet. Blum, Berlin, and Dr. med. vet. Klein, Berlin). These medicines mainly contain sodium thiosulphate together with acidic salts for this purpose Decomposition. Despite the addition of encapsulants such as boluses, these suffer from salt mixtures gradual decomposition. One cannot easily see how far the Decomposition has progressed and whether the mixture has already become ineffective.

Es wurde nun gefunden, daß man durch Zugabe von Ultramarinblau als Indikator in einfachster Weise erkennbar machen kann, ob das Salzgemisch noch brauchbar ist, ferner ob das Salzgemisch nach der Anwendung als W undstreupulver ausreagiert hat, so daß man die betreffende Wunde von neuem behandeln kann.It has now been found that by adding ultramarine blue as Indicator can show in the simplest way whether the salt mixture is still usable is, furthermore, whether the salt mixture reacts completely after use as wound powder so that you can treat the wound again.

Benutzt man die betreffenden Sälzgemische zu Schafwaschmitteln oder Schafbädern, so erweist sich ebenfalls das Ultramarinblau günstig als Indikator, indem man nach dem Auflösen des Salzgemisches wartet, bis die blaue Farbe des Bades verschwunden ist, weil man dann sicher ist, daß alsdann die entbundene schweflige Säure völlig im Bade gelöst und der entbundene kolloidale Schwefel im Bade fein verteilt ist. Durch die Gegenwart der schwefligen Säure wird überdies verhindert, daß die sauren Salze aus dem Ultramarinblau den widerlich riechenden Schwefelwasserstoff freimachen, weil der Schwefelwasserstoff im Augenblicke des Entstehens durch die gelöste schweflige Säure zu kolloidalem Schwefel zersetzt wird.If you use the salt mixtures in question for sheep's detergents or Sheep baths, the ultramarine blue also proves to be a favorable indicator, by waiting for the bath to turn blue after the salt mixture has dissolved has disappeared, because one is then sure that then the sulfurous which has been delivered The acid is completely dissolved in the bath and the released colloidal sulfur is fine in the bath is distributed. The presence of the sulphurous acid also prevents that the acidic salts of the ultramarine blue give the disgusting smelling hydrogen sulfide free because the hydrogen sulfide at the moment of formation by the dissolved sulphurous acid is decomposed to colloidal sulfur.

Ausführungsbeispiel 6oo Teile Natrium thiosulphuricum siccum werden mit 395 Teilen Acidum tartaricum purum siccum pulverisatum subtile und 5 Teilen Ultramarin unter Vermeidung starken Reibens vermischt und hernach sofort in luftdichte und lichtdichte Verpackungen abgefüllt. Das Gemisch ist kühl zu lagern.Embodiment 600 parts of sodium thiosulphuricum siccum are with 395 parts of Acidum tartaricum purum siccum pulverisatum subtle and 5 parts Ultramarine mixed while avoiding strong rubbing and immediately afterwards in airtight and filled light-tight packaging. The mixture must be stored in a cool place.

Claims (1)

PATENT-ANSPRUCH: Verfahren zur Herstellung von Arzneimitteln, die schweflige Säure und kolloidalen Schwefel abspalten, dadurch gekennzeichnet, daß zu Gemischen von Thiosulfaten und sauren Salzen zur Erkennbarmachung des Endpunktes der Umsetzung Ultramarinblau zugesetzt wird.PATENT CLAIM: Process for the production of drugs that Splitting off sulphurous acid and colloidal sulfur, characterized in that on mixtures of thiosulphates and acidic salts to make the end point recognizable ultramarine blue is added to the reaction.
DEK80769D 1922-02-11 1922-02-11 Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur Expired DE379436C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEK80769D DE379436C (en) 1922-02-11 1922-02-11 Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEK80769D DE379436C (en) 1922-02-11 1922-02-11 Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur

Publications (1)

Publication Number Publication Date
DE379436C true DE379436C (en) 1923-08-22

Family

ID=7233965

Family Applications (1)

Application Number Title Priority Date Filing Date
DEK80769D Expired DE379436C (en) 1922-02-11 1922-02-11 Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur

Country Status (1)

Country Link
DE (1) DE379436C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2551627A (en) * 1941-01-02 1951-05-08 Norsk Sulfo Aktieselskap Stabilized polythionates as medicinal cosmetics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2551627A (en) * 1941-01-02 1951-05-08 Norsk Sulfo Aktieselskap Stabilized polythionates as medicinal cosmetics

Similar Documents

Publication Publication Date Title
DE1617320C3 (en) Skin treatment agents
DE379436C (en) Process for the production of pharmaceuticals that split off sulphurous acid and colloidal sulfur
DE554349C (en) Process for the production of foams
US1870123A (en) Embalming fluid
DE1066693B (en) Detergents and disinfectants
DE616362C (en) Head massagers
DE713257C (en) Disinfectants
DE467179C (en) Process for preparing silver salt photographic emulsions
DE1967088C3 (en) N3 disubstituted cysteines
DE938744C (en) Cosmetics, in particular skin and hair care products
DE689373C (en) Process for the production of a sulfur-containing soap
DE630344C (en) Process for making anhydrous toothpastes
US1612742A (en) Active-chlorine preparation
DE966040C (en) Hair care products
DE493055C (en) Insecticides
DE492976C (en) Process for the production of stable and storable, hydrogen sulfide-evolving preparations
DE412424C (en) Process for making soaps
DE959586C (en) Process for making a dentifrice
US1470795A (en) Medicinal compound for cows
DE419676C (en) Process for the production of indecomposable and injectable solutions for medicinal purposes containing calcium and silicon compounds at the same time
DE750765C (en) Preparations for cleaning the human body or parts thereof
DE630404C (en) Disinfectants
DE369080C (en) Process for the production of carbonic acid developing mixtures for the treatment of wounds and body cavities
DE543380C (en) Process for the production of disinfectants
US1255335A (en) Method and means for applying iodin and iodin compounds.